Risk of venous thromboembolism in COVID-19 infection

Meeri Honkanen; Simo Sirkeoja; Hanna Viskari; Ville Kailankangas; Marjatta Sinisalo; Jaana Syrjänen

doi:10.1111/imj.16145

Risk of venous thromboembolism in COVID-19 infection

Intern Med J. 2023 Aug;53(8):1478-1480. doi: 10.1111/imj.16145. Epub 2023 Jul 14.

Authors

Meeri Honkanen¹, Simo Sirkeoja¹, Hanna Viskari¹, Ville Kailankangas¹, Marjatta Sinisalo¹, Jaana Syrjänen¹

Affiliation

¹ Department of Internal Medicine, Tampere University Hospital and Faculty of Medicine and Life Sciences, Tampere University, Tampere, Finland.

PMID: 37449583
DOI: 10.1111/imj.16145

Abstract

The incidence of venous thromboembolism (VTE) for non-hospitalised patients with coronavirus disease-2019 infection has not been very widely studied. 13 019 persons with a positive SARS-CoV-2 nucleic acid amplification test were identified. In total, 447 (0.2%) VTEs were identified in the study population, 293 (66%) of these were pulmonary embolisms. A positive SARS-CoV-2 test did not increase the risk for VTE in the univariate analysis (odds ratio (OR): 1.0, 95% confidence interval (CI): 0.69-1.4) or multivariable analysis (OR: 1.36, 95% CI: 0.93-1.97).

Keywords: COVID-19; epidemiology; outpatients; pulmonary embolism; venous thromboembolism.

Publication types

Comment

MeSH terms

COVID-19* / complications
Humans
Pulmonary Embolism* / diagnosis
Pulmonary Embolism* / epidemiology
Pulmonary Embolism* / etiology
Risk Factors
SARS-CoV-2
Venous Thromboembolism* / diagnosis
Venous Thromboembolism* / epidemiology
Venous Thromboembolism* / etiology
Venous Thrombosis*